Amrubicin and carboplatin with pegfilgrastim in patients with extensive stage small cell lung cancer: A phase II trial of the Sarah Cannon Oncology Research Consortium-Reference-Cited by-同舟云学术

Amrubicin and carboplatin with pegfilgrastim in patients with extensive stage small cell lung cancer: A phase II trial of the Sarah Cannon Oncology Research Consortium

Published:2018-03 Issue: Volume:117 Page:38-43
ISSN:0169-5002
Container-title:Lung Cancer
language:en
Short-container-title:Lung Cancer

Author:

Spigel David R.,Hainsworth John D.,Shipley Dianna L.,Mekhail Tarek M.,Zubkus John D.,Waterhouse David M.,Daniel Davey B.,Burris Howard A.,Greco F. Anthony

Publisher

Elsevier BV

Subject

Cancer Research,Pulmonary and Respiratory Medicine,Oncology

Reference17 articles.

1. Cancer treatment and survivorship statistics, 2016;Miller;CA. Cancer J. Clin.,2016

2. Antitumor activities of a novel 9-aminoanthracycline (SM-5887) against mouse experimental tumors and human tumor xenografts;Morisada;Jpn. J. Cancer Res.,1989

3. Phase II trial of amrubicin in patients with previously treated small cell lung cancer;Kato;J. Clin. Oncol.,2006

4. Phase II trial of amrubicin for treatment of refractory or relapsed small-cell lung cancer: Thoracic Oncology Research Group Study 0301;Onoda;J. Clin. Oncol.,2006

5. Randomized phase II trial of single-agent amrubicin or topotecan as second-line treatment for patients with small-cell lung cancer sensitive to first-line platinum-based chemotherapy;Jotte;J. Clin. Oncol.,2011

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Apatinib inhibits the growth of small cell lung cancer via a mechanism mediated by VEGF, PI3K/Akt and Ki‐67/CD31;Journal of Cellular and Molecular Medicine;2021-09-30

2. Systematic review of first-line chemotherapy for chemo-naïve extensive-stage small-cell lung cancer: network meta-analysis;Therapeutic Advances in Medical Oncology;2020-01

3. Traitement médical du cancer bronchique à petites cellules : peut-on sortir de l’aire du cisplatine–étoposide ?;Bulletin du Cancer;2018-10